Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1997 Nov;179(21):6626–6632. doi: 10.1128/jb.179.21.6626-6632.1997

Characterization of DNA topoisomerase activity in two strains of Mycoplasma fermentans and in Mycoplasma pirum.

S Horowitz 1, R Maor 1, E Priel 1
PMCID: PMC179588  PMID: 9352909

Abstract

DNA topoisomerases (topos) are essential enzymes that participate in many cellular processes involving DNA. The presence of the DNA-gyrase genes in various mycoplasmas has been reported elsewhere. However, the characterization of DNA topo activity in mycoplasmas has not been previously undertaken. In this study, we characterized the topo activity in extracts of Mycoplasma fermentans K7 and incognitus and in Mycoplasma pirum, as well as in partially purified extract of M. fermentans K7. The topo activity in these microorganisms had the following properties. (i) The relaxation of supercoiled DNA was ATP dependent. (ii) ATP independent relaxation activity was not detected. (iii) Supercoiling of relaxed topoisomers was not observed. (iv) The relaxation activity was inhibited by DNA gyrase and topo IV antagonists (novobiocin and oxolinic acid) and by eukaryotic topo II (m-AMSA [4'-(9-acridylamino)methanesulfon-m-anisidide]) and topo I antagonists (camptothecin). Other eukaryotic topo II antagonists (teniposide and etoposide) did not affect the topo relaxation activity. (v) Two polypeptides of 66 and 180 kDa were found to be associated with the mycoplasma topo activity. These results suggest that the properties of the topo enzyme in these mycoplasma species resemble those of the bacterial topo IV and the eukaryotic and the bacteriophage T4 topo II. The findings that mycoplasma topo is inhibited by both eukaryotic topo II and topo I antagonists and that m-AMSA and camptothecin inhibited the growth of M. fermentans K7 in culture support our conclusion that these mycoplasma species have topo with unique properties.

Full Text

The Full Text of this article is available as a PDF (674.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bailey C. C., Bott K. F. An unusual gene containing a dnaJ N-terminal box flanks the putative origin of replication of Mycoplasma genitalium. J Bacteriol. 1994 Sep;176(18):5814–5819. doi: 10.1128/jb.176.18.5814-5819.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bailey C. C., Younkins R., Huang W. M., Bott K. F. Characterization of genes encoding topoisomerase IV of Mycoplasma genitalium. Gene. 1996 Feb 2;168(1):77–80. doi: 10.1016/0378-1119(95)00718-0. [DOI] [PubMed] [Google Scholar]
  3. Colman S. D., Hu P. C., Bott K. F. Mycoplasma pneumoniae DNA gyrase genes. Mol Microbiol. 1990 Jul;4(7):1129–1134. doi: 10.1111/j.1365-2958.1990.tb00687.x. [DOI] [PubMed] [Google Scholar]
  4. Forsyth M. H., Sayed A. S., Geary S. J. Sequence and transcriptional analysis of the genes encoding the class-II topoisomerase of Mycoplasma gallisepticum. Gene. 1995 Sep 22;163(1):161–162. doi: 10.1016/0378-1119(95)00440-h. [DOI] [PubMed] [Google Scholar]
  5. Gellert M. DNA topoisomerases. Annu Rev Biochem. 1981;50:879–910. doi: 10.1146/annurev.bi.50.070181.004311. [DOI] [PubMed] [Google Scholar]
  6. Ghai J., Das A. The virD operon of Agrobacterium tumefaciens Ti plasmid encodes a DNA-relaxing enzyme. Proc Natl Acad Sci U S A. 1989 May;86(9):3109–3113. doi: 10.1073/pnas.86.9.3109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Huang W. M. Nucleotide sequence of a type II DNA topoisomerase gene. Bacteriophage T4 gene 39. Nucleic Acids Res. 1986 Oct 10;14(19):7751–7765. doi: 10.1093/nar/14.19.7751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Huang W. M. The 52-protein subunit of T4 DNA topoisomerase is homologous to the gyrA-protein of gyrase. Nucleic Acids Res. 1986 Sep 25;14(18):7379–7390. [PMC free article] [PubMed] [Google Scholar]
  9. Huff A. C., Leatherwood J. K., Kreuzer K. N. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli. Proc Natl Acad Sci U S A. 1989 Feb;86(4):1307–1311. doi: 10.1073/pnas.86.4.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kato J., Nishimura Y., Imamura R., Niki H., Hiraga S., Suzuki H. New topoisomerase essential for chromosome segregation in E. coli. Cell. 1990 Oct 19;63(2):393–404. doi: 10.1016/0092-8674(90)90172-b. [DOI] [PubMed] [Google Scholar]
  11. Kreuzer K. N., Jongeneel C. V. Escherichia coli phage T4 topoisomerase. Methods Enzymol. 1983;100:144–160. doi: 10.1016/0076-6879(83)00051-8. [DOI] [PubMed] [Google Scholar]
  12. Ladefoged S. A., Christiansen G. Sequencing analysis reveals a unique gene organization in the gyrB region of Mycoplasma hominis. J Bacteriol. 1994 Sep;176(18):5835–5842. doi: 10.1128/jb.176.18.5835-5842.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Liu L. F. DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem. 1989;58:351–375. doi: 10.1146/annurev.bi.58.070189.002031. [DOI] [PubMed] [Google Scholar]
  14. Lo S. C., Tsai S., Benish J. R., Shih J. W., Wear D. J., Wong D. M. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science. 1991 Mar 1;251(4997):1074–1076. doi: 10.1126/science.1705362. [DOI] [PubMed] [Google Scholar]
  15. Matsrafi L., Aflalo E., Blair D. G., Priel E. Isolation of an 11-kDa protein associated with the topoisomerase I activity from equine infectious anemia virus. Biochem Biophys Res Commun. 1996 Mar 27;220(3):1028–1035. doi: 10.1006/bbrc.1996.0527. [DOI] [PubMed] [Google Scholar]
  16. Maxwell A., Gellert M. Mechanistic aspects of DNA topoisomerases. Adv Protein Chem. 1986;38:69–107. doi: 10.1016/s0065-3233(08)60526-4. [DOI] [PubMed] [Google Scholar]
  17. Mizuuchi K., O'Dea M. H., Gellert M. DNA gyrase: subunit structure and ATPase activity of the purified enzyme. Proc Natl Acad Sci U S A. 1978 Dec;75(12):5960–5963. doi: 10.1073/pnas.75.12.5960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Peng H., Marians K. J. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions. J Biol Chem. 1993 Nov 15;268(32):24481–24490. [PubMed] [Google Scholar]
  19. Peng H., Marians K. J. The interaction of Escherichia coli topoisomerase IV with DNA. J Biol Chem. 1995 Oct 20;270(42):25286–25290. doi: 10.1074/jbc.270.42.25286. [DOI] [PubMed] [Google Scholar]
  20. Roca J. The mechanisms of DNA topoisomerases. Trends Biochem Sci. 1995 Apr;20(4):156–160. doi: 10.1016/s0968-0004(00)88993-8. [DOI] [PubMed] [Google Scholar]
  21. Sander M., Hsieh T. Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster. J Biol Chem. 1983 Jul 10;258(13):8421–8428. [PubMed] [Google Scholar]
  22. Sano K., Miyata M. The gyrB gene lies opposite from the replication origin on the circular chromosome of Mycoplasma capricolum. Gene. 1994 Dec 30;151(1-2):181–183. doi: 10.1016/0378-1119(94)90653-x. [DOI] [PubMed] [Google Scholar]
  23. Shuman S., Moss B. Identification of a vaccinia virus gene encoding a type I DNA topoisomerase. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7478–7482. doi: 10.1073/pnas.84.21.7478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Siedlecki J., Zimmermann W., Weissbach A. Characterization of a prokaryotic topoisomerase I activity in chloroplast extracts from spinach. Nucleic Acids Res. 1983 Mar 11;11(5):1523–1536. doi: 10.1093/nar/11.5.1523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sinha B. K. Topoisomerase inhibitors. A review of their therapeutic potential in cancer. Drugs. 1995 Jan;49(1):11–19. doi: 10.2165/00003495-199549010-00002. [DOI] [PubMed] [Google Scholar]
  26. Wang J. C. DNA topoisomerases as targets of therapeutics: an overview. Adv Pharmacol. 1994;29A:1–19. doi: 10.1016/s1054-3589(08)60537-2. [DOI] [PubMed] [Google Scholar]
  27. Wang J. C. DNA topoisomerases. Annu Rev Biochem. 1985;54:665–697. doi: 10.1146/annurev.bi.54.070185.003313. [DOI] [PubMed] [Google Scholar]
  28. Wang J. C. DNA topoisomerases: why so many? J Biol Chem. 1991 Apr 15;266(11):6659–6662. [PubMed] [Google Scholar]
  29. von Rosenstiel N., Adam D. Quinolone antibacterials. An update of their pharmacology and therapeutic use. Drugs. 1994 Jun;47(6):872–901. doi: 10.2165/00003495-199447060-00003. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES